Controlled Release Properties Research Articles

Exploring sustainable agriculture: Investigating the impact of controlled release fertilizer damage through bonded particle modeling

Controlled release technology of chemical fertilizers is an important cornerstone for the efficient development of sustainable agriculture. Damage to the coating layer and fragmentation of particles during the application of controlled release fertilizers can lead to the loss of their controlled release properties, making the development of effective damage reduction operations a key focus in the study of such agricultural materials. Therefore, this paper employs the bonded particle model (BPM) method within the discrete element method (DEM) framework to investigate the mechanism of coating damage in controlled-release fertilizers. It establishes a classification of damage types based on the level of damaged particles as an effective analytical approach. Furthermore, a comparative analysis is conducted between the discrete element particle model (DEPM) method and the bonded particle model method in terms of their performance in discharge mechanics and flow characteristics. The results indicate that the breakage rate of fertilizer discharge is influenced by both the formation of a steady state and the depletion of the fertilizer load within the container, with an average breakage rate of 1.511% over the total period. Differences in the average maximum compression force and mass flow rate between the discrete element particle model group and the bonded particle model group were 60.355 N and 1.998 g/s, respectively, reflecting limitations imposed by the fertilizer models on expected damage deformation behaviors. This study elucidates the process and potential impacts of fertilizer particle damage and deformation, revealing the strengths and limitations of two simulation model approaches under different application conditions, providing insights for sustainable agricultural production and technological innovation in fertilization equipment.

A novel xanthan-chitosan based peroxydisulfate controlled-release material for in-situ sustained degradation of tetracycline: Performance, mechanism and application

In situ chemical oxidation (ISCO) is a promising technology to remove the organic pollutants from groundwater on site. In order to ensure the sustainable and long-term treatment performance, the oxidant controlled-release materials (CRMs) are required. In this study, a novel environmentally friendly and low-cost peroxydisulfate CRM (XG/CS-PDS) was synthesized via the mixing and mold method with xanthan, polyvinyl alcohol and chitosan as the binders for the first time. The XG/CS-PDS possessed significantly stable controlled-release properties under different pH and co-anions. 80% PDS in the CRMs could continuously and slowly release within 50 days. The simulation of PDS controlled-release process indicated that the process was controlled by the non-Fickian diffusion. Then the as-prepared CRM was applied to remove tetracycline (TC) from synthesized groundwater with nanoscale zero-valent iron (nZVI) as the PDS activator. The XG/CS-PDS/nZVI system could achieve 100% removal efficiency at different initial TC concentrations (5‐40 mg/L) and had a good anti-interference ability to pH, inorganic co-anions and humic acid. The quenching experiments and electron spin resonance (ESR) revealed that SO4•-, •OH and 1O2 were the main reactive oxygen species (ROS) for the degradation of TC, while SO4•- played the more dominant role. The intermediates and possible degradation pathway of TC were proposed and the toxicity of TC and its intermediates were evaluated. This study provided a new conception for the design of controlled-release material and theoretical strategies for in-situ remediation of groundwater.

Simulation of in vitro embolization effect of drug-loaded microspheres

Drug-loaded microspheres are widely used in transcatheter arterial chemoembolization (TACE). Controlled drug release from drug-loaded microspheres reduces systemic toxicity, thus necessitating the development of microspheres with controlled release properties. In this study, three different sizes of sodium hyaluronate microspheres (SH) were prepared by a one-step solution drying method using 1,4-butanediol diglycidyl ether (BDDE) as a crosslinking agent. The average sizes of the three SH microspheres (small, medium and large) were 410 μm, 550 μm and 750 μm, respectively. The morphology of the small-sized SH microspheres (SS-SH) was solid spherical; the medium-sized SH microspheres (MS-SH) were semi-hollow spherical; and the large-sized SH microspheres (LS-SH) had a bowl with an opening on one side and a cavity inside. A drug-loaded microsphere (DOX@SH) was prepared by immersing SH microspheres in a doxorubicin hydrochloride (DOX) solution. The average size of the three DOX@SH microspheres increased to 607 μm, 876 μm and 1187 μm, respectively. The encapsulation efficiencies of small, medium and large-sized SH microspheres reached 97.09 %, 96.73 % and 74.87 % at 2 h in a 2 mg/mL DOX solution. The maximum drug loadings of the small, medium and large-sized SH microspheres were 0.38, 0.38 and 0.33 mg DOX/mg SH, respectively. All sizes of DOX@SH microspheres could be controlled and sustained to release and reach equilibrium after 48 h. The cumulative release rates of small, medium and large-sized DOX@SH microspheres (SS-DOX@SH, MS-DOX@SH and LS-DOX@SH) at 72 h were 24.3 %, 28.1 % and 33.8 % in a release medium of pH 6.5, respectively. Blood compatibility and cytotoxicity tests demonstrated that SH microspheres exhibit good biocompatibility. The cytotoxicity of DOX@SH microspheres to HepG2 cells and the uptake of DOX in HepG2 cells showed effective anti-tumor activity. Simulated embolization in vitro experiments indicated that the small-sized DOX@SH microspheres had a good embolization effect for 500–800 μm and 300–500 μm blood vessels. These findings indicate that the newly developed DOX@SH microspheres can be used as a promising drug-loaded embolization agent to enhance the treatment of hepatocellular carcinoma.

Design of mucoadhesive thiomer/organically modified montmorillonite nanocomposites: Evaluation of controlled drug release

This present work introduces a novel thiomer/nanoclay nanocomposite material with mucoadhesive and controlled release properties that has been prepared and evaluated as a potential drug carrier system. This hybrid material is based on thiolated alginate and organically modified montmorillonite (MMT). Alginate thiomer was synthesized by immobilization of l-cysteine on alginate backbone via carbodiimide reaction. Thiol/disulfide groups were identified and quantified by FT-IR, 1H NMR and Ellman's method. Rheological assays as preliminary in vitro mucoadhesion test using mucin show that complex viscosity increases until ∼7-fold compared to unmodified alginate/mucin, and G’ > G″ is present in thiomers, compared with G” > G′ present in unmodified alginate, which indicate strong interactions between thiomer and mucin. Thiomer/nanoclay nanocomposites were prepared by film casting method and characterized by TGA, XRD, TEM and rheometry. Nanocomposites maintain rheological properties showed by thiolated alginate when they are tested with mucin, increasing complex viscosity until ∼8-fold respect a nanocomposite formulation based on unmodified alginate. The release of deltamethrin from nanocomposite films was studied and the impact of the amount of nanoclay (0–7%) and four types of organic modifiers in MMT were evaluated. Different kinetic models were evaluated in order to study the mechanism involved in drug release. Zero, first, Higuchi and Korsmeyer-Peppas model were evaluated, being the last two kinetic models the ones with better fitting and higher values of R2. The presence of nanoclay on the formulation influence significantly (P < 0.001) deltamethrin short-term release showing an anomalous and Case-II transport mechanism. Compared with a Fickian diffusion when nanoclay is absent in the formulation. The diffusion coefficient D could decrease until ∼7-fold compared to a formulation without nanoclay. Long-term release is significantly influenced (P < 0.0001) by the chemical nature of organic modifier used on nanoclay and its interaction with the drug. This thiomer/nanoclay nanocomposite material could be a useful prospect as a mucoadhesive material for drug carrier with controlled drug release properties.

Biofilm microenvironment-activated multimodal therapy nanoplatform for effective anti-bacterial treatment and wound healing

Antimicrobial drug development faces challenges from bacterial resistance, biofilms, and excessive inflammation. Here, we design an intelligent nanoplatform utilizing mesoporous silica nanoparticles doped with copper ions for loading copper sulfide (DM/Cu2+-CuS). The mesoporous silica doped with tetrasulfide bonds responds to the biofilm microenvironment (BME), releasing Cu2+ions, CuS along with hydrogen sulfide (H2S) gas. The release of hydrogen sulfide within 72 h reached 793.5 µM, significantly higher than that observed with conventional small molecule donors. H2S induces macrophages polarization towards the M2 phenotype, reducing inflammation and synergistically accelerating endothelial cell proliferation and migration with Cu2+ions. In addition, H2S disrupts extracellular DNA within biofilms, synergistically photothermal enhanced peroxidase-like activity of CuS to effectively eradicate biofilms. Remarkably, DM-mediated consumption of endogenous glutathione enhances the anti-biofilm activity of H2S and improves oxygen species (ROS) destruction efficiency. The combination of photothermal therapy (PTT), chemodynamic therapy (CDT), and gas treatment achieves sterilization rates of 99.3 % and 99.6 % against Staphylococcus aureus (S. aureus) and Escherichia coli (E. coli), respectively, in vitro under 808 nm laser irradiation. Additionally, in vivo experiments demonstrate a significant biosafety and antibacterial potential. In summary, the H2S donor developed in this study exhibits enhanced biocompatibility and controlled release properties. By integrating BME-responsive gas therapy with antibacterial ions, PTT and CDT, a synergistic multimodal strategy is proposed to offer new therapeutic approaches for wound healing. Statement of significanceThe advanced DMOS/Cu2+-CuS (DMCC) multimodal therapeutic nanoplatform has been developed for the treatment of drug-resistant bacterial wound infections and has exhibited enhanced therapeutic efficacy through the synergistic effects of photothermal therapy, chemodynamic therapy, Cu2+ions, and H2S. The DMCC exhibited exceptional biocompatibility and could release CuS, Cu2+, and H2S in response to elevated concentrations of glutathione within the biofilm microenvironment. H2S effectively disrupted the biofilm structure. Meanwhile, peroxidase activity of CuS combined with GSH-mediated reduction of Cu2+ to Cu+ generated abundant hydroxyl radicals under acidic conditions, leading to efficient eradication of pathogenic bacteria. Furthermore, both H2S and Cu2+ could modulate M2 macrophages polarization and regulate immune microenvironment dynamics. These strategies collectively provided a novel approach for developing antibacterial nanomedical platforms.

Antibacterial and Osteogenic Doxycycline Imprinted Bioglass Microspheres to Combat Bone Infection.

Currently, postoperative infection is a significant challenge in bone and dental surgical procedures, demanding the exploration of innovative approaches due to the prevalence of antibiotic-resistant bacteria. This study aims to develop a strategy for controlled and smart antibiotic release while accelerating osteogenesis to expedite bone healing. In this regard, temperature-responsive doxycycline (DOX) imprinted bioglass microspheres (BGMs) were synthesized. Following the formation of chitosan-modified BGMs, poly N-isopropylacrylamide (pNIPAm) was used for surface imprinting of DOX. The temperature-responsive molecularly imprinted polymers (MIPs) exhibited pH and temperature dual-responsive adsorption and controlled-release properties for DOX. The temperature-responsive MIP was optimized by investigating the molar ratio of N,N'-methylene bis(acrylamide) (MBA, the cross-linker) to NIPAm. Our results demonstrated that the MIPs showed superior adsorption capacity (96.85 mg/g at 35 °C, pH = 7) than nonimprinted polymers (NIPs) and manifested a favorable selectivity toward DOX. The adsorption behavior of DOX on the MIPs fit well with the Langmuir model and the pseudo-second-order kinetic model. Drug release studies demonstrated a controlled release of DOX due to imprinted cavities, which were fitted with the Korsmeyer-Peppas kinetic model. DOX-imprinted BGMs also revealed comparable antibacterial effects against Staphylococcus aureus and Escherichia coli to the DOX (control). In addition, MIPs promoted viability and osteogenic differentiation of MG63 osteoblast-like cells. Overall, the findings demonstrate the significant potential of DOX-imprinted BGMs for use in bone defects. Nonetheless, further in vitro investigations and subsequent in vivo experiments are warranted to advance this research.

Synthesis, Characterization, and Control Release of Zinc Layered Nitrate Intercalated with Beta-Napthoxyacetic Acid (BNOA) Nanocomposite

In this research, the synthesis of the host using zinc nitrate-hexahydrate as a precursor to form zinc layered nitrate (ZLN) and the guest anion which is beta-napthoxyacetic acid (BNOA) will be intercalated with the ZLN to produce nanocomposites called ZLN/beta-napthoxyacetic acid (ZLNB). The method used for the synthesis of the host was self-assembly and ion exchange. The nanocomposites were confirmed with the basal spacing increases from 9.8 to 28.2 Å by using powder X-ray diffraction (PXRD). Therefore, proved the bigger basal spacing compared to the layered double hydroxide of MgAl and ZnAl. The appearance of the FTIR shift band at 1603 cm−1 of C=C aromatic ring indicates that the anions have been successfully incorporated into the interlayers of ZLNB. Moreover, the loading percentage estimated by the carbon content from the ZLNB determined by CHNS analyzer was 41.8% (w/w). The morphology analysis confirmed the plate-like structure for ZLN into flaky-like with irregular, porous and unambiguous structure for ZLNB by field emission scanning electron microscopy (FESEM). The controlled release property showed that the release of BNOA in the various aqueous solutions is in the order of Na3PO4 &gt; Na2SO4 &gt; NaCl and fitted into pseudo-second-order kinetic models.

Integrated oral microgel system ameliorates renal fibrosis by hitchhiking co-delivery and targeted gut flora modulation

BackgroundRenal fibrosis is a progressive process associated with chronic kidney disease (CKD), contributing to impaired kidney function. Active constituents in traditional Chinese herbs, such as emodin (EMO) and asiatic acid (AA), exhibit potent anti-fibrotic properties. However, the oral administration of EMO and AA results in low bioavailability and limited kidney accumulation. Additionally, while oral probiotics have been accepted for CKD treatment through gut microbiota modulation, a significant challenge lies in ensuring their viability upon administration. Therefore, our study aims to address both renal fibrosis and gut microbiota imbalance through innovative co-delivery strategies.ResultsIn this study, we developed yeast cell wall particles (YCWPs) encapsulating EMO and AA self-assembled nanoparticles (NPYs) and embedded them, along with Lactobacillus casei Zhang, in chitosan/sodium alginate (CS/SA) microgels. The developed microgels showed significant controlled release properties for the loaded NPYs and prolonged the retention time of Lactobacillus casei Zhang (L. casei Zhang) in the intestine. Furthermore, in vivo biodistribution showed that the microgel-carried NPYs significantly accumulated in the obstructed kidneys of rats, thereby substantially increasing the accumulation of EMO and AA in the impaired kidneys. More importantly, through hitchhiking delivery based on yeast cell wall and positive modulation of gut microbiota, our microgels with this synergistic strategy of therapeutic and modulatory interactions could regulate the TGF-β/Smad signaling pathway and thus effectively ameliorate renal fibrosis in unilateral ureteral obstruction (UUO) rats.ConclusionIn conclusion, our work provides a new strategy for the treatment of renal fibrosis based on hitchhiking co-delivery of nanodrugs and probiotics to achieve synergistic effects of disease treatment and targeted gut flora modulation.Graphical

Development and evaluation of guar gum-coated nano-nutriosomes for cyanidin-3-O-glucoside encapsulation

Cyanidin-3-O-glucoside (C3G) is a type of water-soluble flavonoid compound that is abundantly found in fruits and vegetables. C3G possesses numerous biological activities, however, it is prone to breakdown under environmental conditions. To overcome these issues, we developed nano-nutriosome (NS) carriers created by vortex-mixing and probe-sonication techniques for C3G encapsulation in which the phospholipid and Nutriose® FB06 were chosen as carrier material, and guar gum (GG) as a coating material to formulate a unilamellar and multicompartment structure. This study aimed to develop and evaluate C3G-loaded nano-nutriosomes coated by GG (GG-C3G-NS) for improving physicochemical stability, antioxidant activity, cellular uptake, and controlled release properties. The C3G-NS and GG-C3G-NS are nanosized (143.47 to 154.13 nm), with high encapsulation efficiency (>93.31 %). The NS carriers successfully encapsulated C3G which was confirmed by transmission electron microscopy, differential scanning calorimetry, and Fourier transform infrared spectroscopy. C3G showed more stability in storage, thermal, pH, ionic, and oxidative conditions. Furthermore, the NS exhibited a better-controlled release of C3G in different food stimulant conditions and in vitro release study. Additionally, NS systems enhanced cellular uptake and showed no cytotoxicity. Overall, GG-NS could be a promising nanocarrier for improving the stability, controlled release, and antioxidant activity of bioactive compounds.

Two-dimensional polydopamine nanosheet-based thermosensitive supramolecular hydrogels for photothermal-chemo synergistic treatment of melanoma

The development of injectable thermosensitive hydrogels with photothermal elimination of tumors and precisely controllable drug release properties is critical for tumor eradication. Herein, a novel injectable thermosensitive supramolecular hydrogel PDAns@CPT-peg/α-CD was developed, which was formed by using two-dimensional polydopamine nanosheets (PDAns) as the photothermal backbone, loaded with the PEGylated camptothecin prodrug (CPT-peg) through π-π stacking and hydrophobic binding, and then crosslinked by the introduction of α-cyclodextrin (α-CD) host–guest self-assembly. PDAns as hydrogel skeleton endowed the hydrogel with excellent photothermal conversion effect, and the large specific surface area of PDAns enables efficient loading of hydrophobic anticancer drugs and avoids undesired leakage. Moreover, the dynamic host–guest cross-linking endows the hydrogel with reversible gel-sol transition and injectability, the gel-sol transition temperature can be easily tunable by the CD concentration, under 808 nm laser irradiation, the PDAns@CPT-peg/α-CD hydrogel can be rapidly heated to the temperature required for photothermal therapy, simultaneously triggering the thermosensitive gel-sol transition followed by the on-demand release of CPT-peg. In vivo evaluation demonstrated that the synergistic photothermal-chemotherapeutic effect mediated by PDAns@CPT-peg/α-CD hydrogel almost eradicated melanoma under low-dose NIR laser (0.15 W cm−2) irradiation. This work provides an effective and convenient strategy for constructing a multifunctional hydrogel platform for the photothermal-chemo synergistic treatment of tumors.

Classification of Oral Ulcers and its Treatment by focusing on Exosome Loaded Hydrogel: A Comprehensive Review

Background: Oral ulcers significantly impact patient quality of life, manifesting as acute or chronic lesions that can cause considerable discomfort and pain. These ulcers arise from a variety of etiological factors and disrupt daily activities due to the painful loss of mucosal tissue. Objective: This review aims to elucidate the etiology and management of oral ulcers, with a focus on innovative treatment modalities involving hydrogels and exosomes. Methods: We reviewed current literature on the pathology and treatment of oral ulcers. Special attention was given to the properties of hydrogels and exosomes, their biomedical applications, and their roles in new therapeutic strategies for oral ulcers. Results: Hydrogels, due to their biocompatibility, biodegradation, and controlled release properties, have emerged as effective drug delivery systems. Exosomes, loaded within these hydrogels, enhance treatment outcomes due to their high cellular communication capacity and anti-inflammatory properties. Conclusion: Innovative treatments utilizing hydrogels and exosomes offer promising alternatives for the management of oral ulcers, potentially improving drug delivery efficiency and patient compliance.

NIR-Responsive Methotrexate-Modified Iron Selenide Nanorods for Synergistic Magnetic Hyperthermic, Photothermal, and Chemodynamic Therapy.

Breast cancer is a malignant tumor with a high mortality rate among women. Therefore, it is necessary to develop novel therapies to effectively treat this disease. In this study, iron selenide nanorods (FeSe2 NRs) were designed for use in magnetic hyperthermic, photothermal, and chemodynamic therapy (MHT/PTT/CDT) for breast cancer. To illustrate their efficacy, FeSe2 NRs were modified with the chemotherapeutic agent methotrexate (MTX). MTX-modified FeSe2 (FeSe2-MTX) exhibited excellent controlled drug release properties. Fe2+ released from FeSe2 NRs induced the release of •OH from H2O2 via a Fenton/Fenton-like reaction, enhancing the efficacy of CDT. Under alternating magnetic field (AMF) stimulation and 808 nm laser irradiation, FeSe2-MTX exerted potent hyperthermic and photothermal effects by suppressing tumor growth in a breast cancer nude mouse model. In addition, FeSe2 NRs can be used for magnetic resonance imaging in vivo by incorporating their superparamagnetic characteristics into a single nanomaterial. Overall, we presented a novel technique for the precise delivery of functional nanosystems to tumors that can enhance the efficacy of breast cancer treatment.

Orally ingestible medication utilizing layered double hydroxide nanoparticles strengthened alginate and hyaluronic acid-based hydrogel bead for bowel disease management

In the treatment of bowel diseases such as ulcerative colitis through oral administration, an effective drug delivery system targeting the colon is crucial for enhancing efficacy and minimizing side effects of therapeutic agents. This study focuses on the development of a novel nanocomposite hydrogel bead comprising a synergistic blend of biological macromolecules, namely sodium alginate (ALG) and hyaluronic acid (HA), reinforced with layered double hydroxide nanoparticles (LDHs) for the oral delivery of dual therapeutics. The synthesized hydrogel bead exhibits significantly enhanced gel strength and controllable release of methylprednisolone (MP) and curcumin (CUR), serving as an anti-inflammatory drug and a mucosal healing agent, compared to native ALG or ALG/HA hydrogel beads without LDHs. The physicochemical properties of the synthesized LDHs and hydrogel beads were characterized using various techniques, including scanning electron microscopy, zeta potential measurement, transmission electron microscopy, X-ray diffraction, and energy-dispersive X-ray spectroscopy. In vitro release studies of MP and CUR under simulated gastrointestinal tract (GIT) conditions demonstrate the superior controlled release property of the nanocomposite hydrogel bead, particularly in minimizing premature drug release in the upper GIT environment while sustaining release of over 82 % of drugs in the colonic environment. Thus, the modularly engineered carrier designed for oral colon targeting holds promise as a potential candidate for the treatment of ulcerative colitis.

Evaluation of the polycaprolactone hydrolytic degradation in acid solvent and its influence on the electrospinning process

AbstractPolycaprolactone (PCL) is a pivotal biopolymer in biomedicine, especially in tissue engineering for scaffolds and biomaterials. Recognized for its effectiveness as a drug carrier with superior controlled release properties, PCL is commonly processed via electrospinning, typically employing chlorinated or fluorinated solvents known for cellular toxicity. As an environmentally conscious alternative, this study explores glacial acetic acid (AA) as a solvent for electrospinning solutions. Investigating PCL's molecular degradation through acid hydrolysis in acidic solvents (AA/formic acid) (FA), the study assesses the impact of storage time on resulting structures. Solutions containing 30% PCL in AA/FA (9:1) were stored at 35°C for up to 14 days, revealing a 50% molar mass reduction during solubilization through gel permeation chromatography, x‐ray diffraction, and Fourier‐transform infrared analyses. This reduction influenced chain packing, raising crystallinity indices from approximately 37% to 49% with prolonged storage. The reduced molar mass resulted in unstable Taylor cones, generating diverse mat morphologies. Intriguingly, this degradation enhanced water adsorption capacity, indicating exposed hydrogen bonds from acid hydrolysis as an advantageous trait for regenerative medicine. This underscores the hydrolyzed materials' potential for cell anchoring in tissue engineering.

The Application of 2d Mxene Nanosheet -Based Thermosensitive Gel Delivery System Loaded with Cisplatin and Imiquimod for Lung Cancer.

Lung cancer's high incidence and dismal prognosis with traditional treatments like surgery and radiotherapy necessitate innovative approaches. Despite advancements in nanotherapy, the limitations of single-treatment modalities and significant side effects persist. To tackle lung cancer effectively, we devised a temperature-sensitive hydrogel-based local injection system with near-infrared triggered drug release. Utilizing 2D MXene nanosheets as carriers loaded with R837 and cisplatin (DDP), encapsulated within a temperature-sensitive hydrogel-forming PEG-MXene@DDP@R837@SHDS (MDR@SHDS), we administered in situ injections of MDR@SHDS into tumor tissues combined with photothermal therapy (PTT). The immune adjuvant R837 enhances dendritic cell (DC) maturation and tumor cell phagocytosis, while PTT induces tumor cell apoptosis and necrosis by converting light energy into heat energy. Material characterization employed transmission electron microscopy, X-ray photoelectron spectroscopy, phase transition temperature, and near-infrared thermography. In vitro experiments assessed Lewis cell proliferation and apoptosis using CCK-8, Edu, and TUNEL assays. In vivo experiments on C57 mouse Lewis transplant tumors evaluated the photothermal effect via near-infrared thermography and assessed DC maturation and CD4+/CD8+ T cell ratios using flow cytometry. The in vivo anti-tumor efficacy of MDR@SHDS was confirmed by tumor growth curve recording and HE and TUNEL staining of tumor sections. The hydrogel exhibited excellent temperature sensitivity, controlled release properties, and high biocompatibility. In vitro experiments revealed that MDR@SHDS combined with PTT had a greater inhibitory effect on tumor cell proliferation compared to MDR@SHD alone. Combining local immunotherapy, chemotherapy, and PTT yielded superior anti-tumor effects than individual treatments. MDR@SHDS, with its simplicity, biocompatibility, and enhanced anti-tumor effects in combination with PTT, presents a promising therapeutic approach for lung cancer treatment, offering potential clinical utility.

Design, fabrication, and evaluation of keratin and pectin incorporated supramolecular structured zero-oxidation state selenium nanogel blended 3D printed transdermal patch

This study investigates the synthesis of selenium nanoparticles (SeNPs), owing to the low cost and abundance of selenium. However, the toxicity of SeNP prompts the development of a selenium nanocomposite (SeNC) containing pectin, keratin, and ferulic acid to improve the bioactivity of Se[0]. Further, incorporating the SeNC in a suitable formulation for drug delivery as a transdermal patch was worth studying. Accordingly, various analytical techniques were used to characterize the SeNPs and the SeNC, confirming successful synthesis and encapsulation. The SeNC exhibited notable particle size of 448.2 ± 50.2 nm, high encapsulation efficiency (98.90 % ± 2.4 %), 28.1 ± 0.45 drug loading, and sustained drug release at pH 5.5. Zeta potential and XPS confirmed the zero-oxidation state. The supramolecular structure was evident from spectral analysis endorsing the semi-crystalline nature of the SeNC and SEM images showcasing flower-shaped structures. Further, the SeNC demonstrated sustained drug release (approx. 22 % at 48 h) and wound-healing potential in L929 fibroblast cells. Subsequently, the SeNC loaded into a gelling agent exhibited shear thinning properties and improved drug release by nearly 58 %. A 3D printed reservoir-type transdermal patch was developed utilizing the SeNC-loaded gel, surpassing commercially available patches in characteristics such as % moisture uptake, tensile strength, and hydrophobicity. The patch, evaluated through permeation studies and CAM assay, exhibited controlled drug release and angiogenic properties for enhanced wound healing. The study concludes that this patch can serve as a smart dressing with tailored functionality for different wound stages, offering a promising novel drug delivery system for wound healing.

Cananga odorata (Ylang-Ylang) Essential Oil Containing Nanoemulgel for the Topical Treatment of Scalp Psoriasis and Dandruff.

This research aimed to evaluate the efficacy of a nanoemulgel (NE) containing Cananga odorata (Ylang-Ylang) oil for managing scalp psoriasis and dandruff through various assessments. The study involved phytochemical screening, characterization, stability testing, in vivo performance evaluation, dermatokinetic analysis, central composite rotatable design (CCRD) optimization, in vitro release profiling, and antioxidant and antimicrobial activity assessment of the NE. The NE exhibited excellent stability and maintained physical parameters over a three-month period. In vivo studies showed no skin irritation, maintenance of skin pH (4.55 to 5.08), and improvement in skin hydration (18.09 to 41.28 AU) and sebum content (26.75 to 5.67 mg/cm2). Dermatokinetic analysis revealed higher skin retention of C. odorata in the NE (epidermis: 71.266 µg/cm2, dermis: 60.179 µg/cm2) compared to conventional formulations. CCRD optimization yielded NE formulations with the desired particle size (195.64 nm), entrapment efficiency (85.51%), and zeta potential (-20.59 mV). In vitro release studies indicated sustained release behavior, and antioxidant and antimicrobial properties were observed. This study demonstrates the stability, skin-friendliness, therapeutic benefits, and controlled release properties of the NE. The NE presents a promising option for various topical applications in treating bacterial and fungal diseases, potentially enhancing drug delivery and treatment outcomes in pharmaceuticals and cosmetics.

Microsponges: Development, Characterization, and Key Physicochemical Properties.

Microsponges are promising drug delivery carriers with versatile characteristics and controlled release properties for the delivery of a wide range of drugs. The microsponges will provide an optimized therapeutic effect, when delivered at the site of action without rupturing, then releasing the cargo at the predetermined time and area. The ability of the microsponges to effectively deliver the drug in a controlled manner depends on the material composition. This comprehensive review entails knowledge on the design parameters of an optimized microsponge drug delivery system and the controlled release properties of microsponges that reduces the side effects of drugs. Furthermore, the review delves into the fabrication techniques of microsponges, the mechanism of drug release from the microsponges, and the regulatory requirements of the U.S. Food and Drug Administration (FDA) for the successful marketing of microsponge formulation. The review also examines the patented formulations of microsponges. The prospects of these sophisticated drug delivery systems for improved clinical outcomes are highlighted.

Biodegradable SPI-based hydrogel for controlled release of nanomedicines: A potential approach against brain tumors recurrence

Glioblastoma (GB) is the most common and aggressive brain tumor. The treatment for newly diagnosed glioblastoma is surgical resection of the primary tumor mass, followed by radiotherapy and chemotherapy. However, recurrences frequently occur in proximity to the surgical resection area. In these cases, none of the current therapies is effective. Recently, implantable biomaterials seem to be a promising strategy against GB recurrence. Here, for the first time we combined the tailorable properties of soy-protein hydrogels with the versatility of drug-loaded liposomes to realize a hybrid biomaterial for controlled and sustained nanoparticles release. Hydrogel consisting of 18–20 % w/v soy-protein isolated were fabricated in absence of chemical cross-linkers. They were biodegradable (−10 % and −30 % of weight by hydrolytic and enzymatic degradation, respectively in 3 days), biocompatible (>95 % of cell viability after treatment), and capable of sustained release of intact doxorubicin-loaded liposomes (diffusion coefficient between 10−18 and 10 −19 m2 s−1). A proof-of-concept in a “donut-like” 3D-bioprinted model shows that liposomes released by hydrogels were able to diffuse in a model with a complex extracellular matrix-like network and a 3D structural organization, targeting glioblastoma cells.The combination of nanoparticles' encapsulation capabilities with the hydrogels' structural support and controlled release properties will provide a powerful tool with high clinical relevance that could be applicable for the treatment of other cancers, realizing patient-specific interventions.

Black rice anthocyanins nanoparticles based on bovine serum albumin and hyaluronic acid: Preparation, characterization, absorption and intestinal barrier function protection in Caco-2 monolayers

Black rice anthocyanins (BRA) nanoparticles (NPs) were prepared using hyaluronic acid (HA), oxidized hyaluronic acid (OHA) and bovine serum albumin (BSA) to enhance the absorption and bioactivity of anthocyanins (ACNs). Results showed that HA/OHA-BSA-BRA NPs had a spherical morphology and excellent dispensability, with hydrated radius ~ 500 nm, zeta potential ~ − 30 mV, and encapsulation efficiency ~21 %. Moreover, using in vitro gastrointestinal release assay, we demonstrated that both BRA-loaded NPs exhibited effective controlled release properties of ACNs, significantly enhancing the accessibility of ACNs to the intestine. Cellular experiments showed that both two NPs had good biocompatibility and increased uptake of BRA. Furthermore, in comparison to the free BRA group, both BRA NPs groups significantly decreased the TEER value and increased the expression of tight junction proteins (Claudin 1, Occludin and ZO-1) in Caco-2 cell monolayers with LPS-induced damage. Therefore, our study demonstrated that HA/OHA-BSA-BRA NPs are promising carriers of ACNs and can effectively prevent the LPS-induced intestinal barrier injury in vitro.